Chinese english Germany Japanese Korea

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate Struktur
154590-62-2
CAS-Nr.
154590-62-2
Englisch Name:
(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate
Synonyma:
(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl]phenyl]-, 1,1-dimethylethyl ester
CBNumber:
CB72617843
Summenformel:
C19H26FN3O5
Molgewicht:
395.43
MOL-Datei:
154590-62-2.mol
Request For Quotation

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate Eigenschaften

Schmelzpunkt:
130-131 °C
Siedepunkt:
552.2±50.0 °C(Predicted)
Dichte
1.297±0.06 g/cm3(Predicted)
pka
14.05±0.10(Predicted)

Sicherheit

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Acesys Pharmatech 18860950986
 tangmanman@zenjipharma.com China 1735 55
Hangzhou Yaoruiyicheng Biological Medicine Co., Ltd 18072846723
 caigou1@witofly.com China 18924 58
  • (R)-tert-butyl 4-(2-fluoro-4-(5-(hydroxyMethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate
  • 1-Piperazinecarboxylic acid, 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl]phenyl]-, 1,1-dimethylethyl ester
  • 154590-62-2
  • C19H26FN3O5
Copyright 2019 © ChemicalBook. All rights reserved